Submissions faster. Across every jurisdiction.

A regulatory affairs platform is software that helps pharmaceutical and life sciences companies manage submissions, registrations, and compliance across health authorities. It centralises submission pipeline tracking, dossier assembly, regulatory intelligence, and labelling management — replacing fragmented spreadsheets and email-based workflows with a unified system that gives regulatory teams real-time visibility across jurisdictions.

AI accelerates regulatory submissions by automating document assembly, flagging gaps in dossier readiness, and drafting sections of clinical study reports per ICH E3 guidelines. It also powers regulatory intelligence — continuously monitoring health authority updates across jurisdictions and surfacing requirement changes that affect your active portfolio. This reduces manual monitoring effort and helps teams catch changes before they delay a submission.

eCTD (electronic Common Technical Document) is the internationally agreed format for submitting regulatory dossiers to health authorities including the FDA, EMA, and PMDA. It organises submission content into a standardised five-module structure covering administrative information, summaries, quality data, nonclinical reports, and clinical study reports. Using eCTD ensures submissions meet format requirements across jurisdictions and enables lifecycle management of regulatory documents through sequence-based updates.

Multi-jurisdiction submissions require tracking different regulatory requirements, timelines, and dossier formats across health authorities such as the FDA, EMA, CDSCO, PMDA, and TGA. Companies typically use a submission pipeline management system that provides a unified view of all active filings, jurisdiction-specific requirement checklists, milestone tracking, and health authority query coordination — enabling regulatory teams to manage parallel submissions without losing visibility.

Regulatory submissions must comply with standards set by the International Council for Harmonisation (ICH), including ICH CTD/eCTD format requirements, ICH E3 for clinical study reports, ICH M4 for the Common Technical Document structure, and jurisdiction-specific regulations from authorities like the FDA (21 CFR), EMA, and regional bodies. A compliant platform enforces document standards, maintains full audit trails, supports version control, and validates submission packages before filing.

Regulatory intelligence is the systematic monitoring, analysis, and interpretation of regulatory developments that affect a pharmaceutical company's portfolio and submission strategy. This includes tracking guideline changes from health authorities, analysing precedent decisions, monitoring competitive filings, and assessing the impact of new requirements on active and planned submissions. AI-powered regulatory intelligence automates this monitoring across multiple jurisdictions simultaneously.

Template-based regulatory platforms can be deployed in 4–8 weeks following a 1–2 week pipeline mapping phase where the team documents active submissions, jurisdiction requirements, and workflow priorities. Custom-built regulatory information management systems typically take 6–12 months or longer. The template approach allows regulatory teams to start tracking submissions and assembling dossiers quickly while customising the platform for their specific jurisdictions and processes over time.

An effective submission pipeline dashboard tracks active and planned submissions by jurisdiction, dossier readiness status and gap analysis, health authority query status and response deadlines, milestone timelines and critical path items, labelling change requests and their cross-jurisdiction impact, and variation/amendment tracking for post-approval changes. These metrics give regulatory leadership real-time visibility into portfolio progress and help identify bottlenecks before they affect market access timelines.